Anton Bilchik Says Ultrasounds Help Detect Early Stage Liver Cancer in Some Patients

Some researchers now suggest that people with cirrhosis, a serious phase of liver disease, have an ultrasound, twice each year, to detect liver cancer in its earliest stages. Cirrhosis occurs when scar tissue forms in the liver in a way that prevents this vital organ from doing its job. Cirrhosis can be the result of a significant injury or long-term illness. Cirrhosis is the primary cause of liver cancer.

Ultrasounds may be more reliable at diagnosing liver cancer in the earliest stages, as compared to computed tomography, or CT. Both CTs and ultrasounds are imaging tools doctors use to look for liver cancer, but CTs and ultrasounds work in slightly different ways. A CT uses x-rays and is best for seeing bone, soft tissue, and blood vessels, all at the same time. An ultrasound uses high-frequency sound waves, rather than radiation, and is used for visualizing soft tissues only.

A physician may order an alpha-fetaprotein, or AFP, blood test. While AFP blood tests are the most commonly used tool for detecting liver cancer, results can vary according to differing levels of sensitivities between tests. Additionally, these tests can return a false positive in patients who have hepatitis, other types of tumors, or who are pregnant.

Dr. Anton Bilchik uses the most advance technologies to detect liver cancer. This leading cancer doctor will then discuss all the options with his patients. Anton Bilchik MD of the John Wayne Cancer Institute in California is highly experienced in all types of gastrointestinal cancer procedures, from minimally invasive procedures, to complex surgeries.